...
首页> 外文期刊>American Journal of PharmTech Research >Preparation of Superporous Hydrogel Composites Drug Delivery System Using Metronidazole as a Model Drug
【24h】

Preparation of Superporous Hydrogel Composites Drug Delivery System Using Metronidazole as a Model Drug

机译:以甲硝唑为模型药物制备超孔水凝胶复合材料给药系统

获取原文
           

摘要

  ABSTRACT The aim of this study is to prepare gastroretentive dosage form based on the super porous hydrogel (SPH) composites using metronidazole as a model drug for eradication of H pylori.Blowing technique was used to prepare SPH composites. The latter was used as a body for the drug delivery system. The core was made from matrix granules. Four types of retardants (Beeswax, carnauba wax, ethylcellulose, and Eudragit®RS) were used to prepare the granules by fusion for waxes and wet granulation methods for other polymers. For each retardants, two ratios (1:1 and 1:0.5 of drug: retardant) were used. Simple new method for insertion of core inside the SPH composite by using syringe with wide end opening without use of glue to close the insertion site was applied. The system was characterized by scanning electron microscopy, FT-IR. Also swelling, mechanical, and dissolution properties were studied. Scanning electron microscopic images clearly show highly porous structure and interconnected channels. FT-IR study confirmed the formation of crosslinking poly (acrylamide- sulfopropyl acrylate) SPH composites. The delivery system achieved the equilibrium swelling in about 3 minutes with swelling ratio of 10.45 ± 0.9 and penetration pressure of 483.34 ± 48.0 cm H2O. The results showed non-significant (p 0.05) difference between loaded and unloaded SPH composites regarding mechanical and swelling properties. A significant difference (P 0.05) was found among the cumulative amount of metronidazole released with time depending on the nature and ratio of each retardant. It can be concluded that the proposed drug delivery system based on superporous hydrogel composite is promising for gastroretentive stomach specific delivery of metronidazole. Key words: Superporous hydrogel composites, Gastroretentive dosage form, metronidazole
机译:摘要本研究旨在以甲硝唑为模型根除幽门螺杆菌的超级多孔水凝胶(SPH)复合材料制备胃滞留剂型,并采用吹气法制备SPH复合材料。后者被用作药物输送系统的主体。芯由基质颗粒制成。四种类型的阻滞剂(蜂蜡,巴西棕榈蜡,乙基纤维素和Eudragit®RS)用于熔融制蜡和其他聚合物的湿法制粒,以制备颗粒。对于每种阻滞剂,使用两个比率(药物:阻滞剂的1:1和1:0.5)。采用了一种简单的新方法,该方法是通过使用具有宽端开口的注射器而不使用胶来封闭插入部位的方法,将芯插入SPH复合材料内部。该系统通过扫描电子显微镜FT-IR进行表征。还研究了溶胀,机械和溶解性能。扫描电子显微镜图像清楚地显示出高度多孔的结构和相互连接的通道。 FT-IR研究证实了交联聚(丙烯酰胺-丙烯酸磺丙酯)SPH复合材料的形成。输送系统在约3分钟内达到了平衡溶胀,溶胀率为10.45±0.9,穿透压力为483.34±48.0 cm H2O。结果表明,就机械性能和溶胀性能而言,加载和未加载的SPH复合材料之间的差异不显着(p> 0.05)。甲硝唑的累积释放量随时间的推移存在显着差异(P <0.05),具体取决于每种阻滞剂的性质和比例。可以得出结论,所提出的基于超多孔水凝胶复合物的药物递送系统有望用于胃滞留性胃特异性甲硝唑的递送。关键词:超多孔水凝胶复合物胃滞留剂型甲硝唑

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号